HomeDNTH • NASDAQ
Dianthus Therapeutics Inc
add
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 1.33M | 190.15% |
Operating expense | 33.24M | 147.83% |
Net income | -28.44M | -169.24% |
Net profit margin | -2.14K | 7.21% |
Earnings per share | -0.81 | — |
EBITDA | -31.89M | -146.52% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 275.24M | 58.44% |
Total assets | 374.01M | 108.47% |
Total liabilities | 21.53M | 104.38% |
Total equity | 352.48M | — |
Shares outstanding | 32.13M | — |
Price to book | 1.88 | — |
Return on assets | -21.91% | — |
Return on capital | -23.05% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -28.44M | -169.24% |
Cash from operations | -27.44M | -131.52% |
Cash from investing | -23.11M | -180.56% |
Cash from financing | 39.68M | 915.54% |
Net change in cash | -10.88M | 56.41% |
Free cash flow | -12.55M | 2.59% |
Previous close
$21.28
Day range
$21.25 - $22.10
Year range
$18.16 - $33.77
Market cap
646.84M USD
Avg Volume
228.31K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2019
Website
Employees
78
